Abstract
Complications of cardiac implantable electronic devices (CIED) are defined as any adverse event that requires either reintervention or additional diagnosis and therapeutic procedures. The complication rate of CIED devices ranges from 4 to 10 %, with a mortality under 0.1 %.
Acute phase and late complications can be related to venous access, lead positioning, and device pocket. There are common and specific complications depending on the electronic device type and the number and localization of the leads.
These complications are still a common problem, and the prevalence of some is increasing, since the implantation rate is increasing and also the complexity of the devices. Their economic impact is important as well as the consequences for the patients, that is why monitoring and treatment of these complications, insuring adequate training, and maintenance of competence should be part of the good clinical practice.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Similar content being viewed by others
References
Haug B, Kjelsberg K, Lappegård KT. Pacemaker implantation in small hospitals: complication rates comparable to larger centres. Europace. 2011;13:1580–6.
Ellenbogen KA, Wood MA. Cardiac pacing and ICDs. 5th ed. Hoboken: Wiley-Blackwell; 2008. p. 245–62.
Eberhardt F, Bode F, Bonnemeier H, et al. Long term complications in single and dual chamber pacing are influenced by surgical experience and patient morbidity. Heart. 2005;91:500–6.
Peterson PN, Daugherty SL, Wang Y, et al. The National Data Registry. Gender differences in procedure-related adverse events in patients receiving implantable cardioverter-defibrillator therapy. Circulation. 2009;119:1078–84.
Tobin K, Stewart J, Westveer D, et al. Acute complications of permanent pacemaker implantation: their financial implications and relation to volume and operator experience. Am J Cardiol. 2000;85:774–7.
Link MS, Estes 3rd NA, Griffin JJ, et al. Complications of dual chamber pacemaker implantation in the elderly. Pacemaker Selection in the Elderly (PASE) Investigators. J Interv Card Electrophysiol. 1998;2:175–9.
Møller M, Arnsbo P, Asklund M, Christensen PD, Gadsbøll N, Svendsen JH, et al. Quality assessment of pacemaker implantations in Denmark. Europace. 2002;4:107–12.
Nowak B, Misselwitz B, Erdogan A, Funck R, Irnich W, Israel C, et al. Do gender differences exist in pacemaker implantation? Results of an obligatory external quality control program. Europace. 2010;12:152–3.
Ellery SM, Paul VE. Complications of biventricular pacing. Eur Heart J Suppl. 2004;6(Suppl D):D117–21.
Reinolds MR, Cohen DJ, Kugelmass AD, et al. The frequency and incremental cost of major complications among Medicare beneficiaries receiving implantable cardioverter-defibrillators. J Am Coll Cardiol. 2006;47:2493–7.
Abraham WT. Rationale and design of a randomized clinical trial to assess the safety and efficacy of cardiac resynchronization therapy in patients with advanced heart failure: the Multicenter InSync Randomized Clinical Evaluation (MIRACLE). J Card Fail. 2000;6(4):369–80.
Luck JC, Wolbrette DL, Boehmer JP, et al. Biventricular pacing in congestive heart failure: a boost toward finer living. Curr Opin Cardiol. 2002;17(1):96–101.
Klug D, Balde M, Pavin D, Hidden-Lucet F, Clementy J, Sadoul N, et al. Risk factors related to infections of implanted pacemakers and cardioverter- defibrillators: results of a large prospective study. Circulation. 2007;116:1349–55.
Pakarinen S, Oikarinen L, Toivonen L. Short-term implantation-related complications of cardiac rhythm management device therapy: a retrospective single-centre 1-year survey. Europace. 2010;12:103–8.
Pescariu S. Implantul de stimulator cardiac. Timisoara: Brumar; 1996. p. 136–51.
Pescariu S. Aritmii. Ghid clinic. Timisoara: Brumar; 2004. p. 170–2.
Timperley J, Leeson P, Mitchell ARJ, et al. Pacemakers and ICDs. Oxford: Oxford University Press; 2008. p. 84–93.
Molnár L, Szucs G, Zima E, et al. Successful management and long term outcome of an accidental subclavian artery injury with a 9 French dilator during pacemaker implantation with collagen-based closure device. J Interv Card Electrophysiol. 2009;25(3):217–8.
Meyhoefer J, Lehmann H, Minden HH, et al. Closure of the subclavian artery puncture site with a percutaneous suture device after removal of an arterial pacemaker lead. Europace. 2006;8(12):1070–2.
Libby P, Bonow RO, Zipes DP, Mann DL. Pacemakers and implantable cardioverter-defibrillators. In: Braunwald’s heart disease, A textbook of cardiovascular medicine. 9th ed. Philadelphia: Elsevier Saunders; 2012. p. 162.
Villalba S, Roda J, Quesada A, et al. Retrospective study of patients who undergo pacemaker implantation in short-stay ambulatory surgery. Long-term follow-up and cost analysis. Rev Esp Cardiol. 2004;57(3):234–40.
Sadamatsu K. Complication of pacemaker implantation: an atrial lead perforation. In: Das MR, editor. Modern pacemakers – present and future. Rijeka: InTech; 2011. doi: 10.5772/13854. ISBN: 978-953-307-214-2.
Al Ahmad A, Ellenbogen KA, Natale A, et al. Pacemakers and implantable cardioverter defibrillators. An expert’s manual. Minneapolis: Cardiotext Publishing; 2010. p. 39–43.
Ellenbogen KA, Wood MA, Shepard RK, et al. Detection and management of an implantable cardioverter lead failure: incidence and clinical implications. J Am Coll Cardiol. 2003;41:73–80.
Ritter F, Fischer W. Pratique de la Stimulation Cardiaque. Paris: Springer; 1997. p. 225–50.
Rozmus G, Daubert JP, Huang DT, et al. Venous thrombosis and stenosis after implantation of pacemakers and defibrillators. J Interv Card Electrophysiol. 2005;13:9–19.
Wiegand UKH, LeJeune D, Boguschewski F, et al. Pocket hematoma after pacemaker or implantable cardioverter defibrillator surgery influence of patient morbidity, operation strategy, and perioperative antiplatelet/anticoagulation therapy. Chest. 2004;126:1177–86.
Van Eck JWM, Van Hemel NM, Zuithof P, et al. Incidence and predictors of in-hospital events after first implantation of pacemakers. Europace. 2007;9:884–9.
Dhua JD, Wilkoff BL, Lee I, et al. Diagnosis and management of infections involving implantable electrophysiologic cardiac devices. Ann Intern Med. 2000;133:604–8.
Uslan DZ, Gleva MJ, Warren DK, et al. Cardiovascular implantable electronic device replacement infections and prevention: results from the REPLACE Registry. Pacing Clin Electrophysiol. 2012;35:81–7.
Greenspon AJ, Patel JD, Lau E, et al. 16 year trends in the infection burden for pacemakers and implantable cardioverter-defibrillators in the United States 1993 to 2008. J Am Coli Cardiol. 2011;58:1001–6.
Yu CM, Hayes DL, Auricchio A. Cardiac resynchronization therapy. London: Blackwell Futura; 2008. p. 214–31.
Cazeau S, Leclercq C, Lavergne T, et al. Effects of multisite biventricular pacing in patients with heart failure and intraventricular conduction delay. N Engl J Med. 2001;344(12):873–80.
Hellerstein HK, Orbison JL. Anatomic variations of the orifice of the human coronary sinus. Circulation. 1951;3:514–23.
Alonso C, Leclercq C, Revault d’Allonnes F, et al. Six year experience of transvenous left ventricular lead implantation for permanent biventricular pacing in patients with advanced heart failure: technical aspects. Heart. 2001;86:405–10.
Lenarczyk R, Kowalski O, Kukulski T, et al. Triple-site biventricular pacing in patients undergoing cardiac resynchronization therapy: a feasibility study. Europace. 2007;9:762–7.
Kowalski O, Lanarczyk R, Prokopczuk J, et al. Effect of percutaneous interventions within the coronary sinus on the success rate of the implantations of resynchronization pacemakers. Pacing Clin Electrophysiol. 2006;29:1075–80.
De Cock CC, van Campen CM, Visser CA. Major dissection of the coronary sinus and its tributaries during lead implantation for biventricular stimulation: angiographic follow up. Europace. 2004;6:43–7.
Mela T, Ngarmukos T, Rosenthal L, et al. Inappropriate ICD therapy due to lead- related noise in an active fixation ICD lead. J Invasive Cardiol. 2001;13(5):406–8.
Bayliss CE, Beanlands DS, Baird RJ. The pacemaker-twiddler’s syndrome: a new complication of implantable transvenous pacemakers. Can Med Assoc J. 1968;99(8):371.
Nery PB, Fernandes R, Nair GM, et al. Device-related infection among patients with pacemakers and implantable defibrillators: incidence, risk factors, and consequences. J Cardiovasc Electrophysiol. 2010;21:786–90.
Habib G, Hoen B, Tornos P, et al. Guidelines on the prevention, diagnosis, and treatment of infective endocarditis (new version 2009). The Task Force on the Prevention, Diagnosis, and Treatment of Infective Endocarditis of the European Society of Cardiology (ESC). Eur Heart J. 2009;30:2369–413.
Chua JD, Wilkoff BL, et al. Diagnosis and management of infections involving implantable electrophysiologic cardiac devices. Ann Intern Med. 2000;133:604–8.
Sohail MR, Uslan DZ, et al. Infective endocarditis complicating permanent pacemaker and implantable cardioverter-defibrillator infection. Mayo Clin Proc. 2008;83(1):46–53.
Ruttman E, Hangler HB, et al. Transvenous pacemaker lead removal is safe and effective even in large vegetations: an analysis of 53 cases of pacemaker lead endocarditis. Pacing Clin Electrophysiol. 2006;29(3):231–6.
Knight BP, Desai A, Coman J, et al. Long- term retention of cardiac resynchronization therapy. J Am Coll Cardiol. 2004;44:72–7.
Leon AR, Abraham WT, Curtis AB et al. Safety of transvenous cardiac resynchronization system implantation in patients with chronic heart failure: combined results of over 2000 patients from a multicenter study program (MIRACLE study program). J Am Coll Cardiol. 2005;46:2348–56.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2014 Springer-Verlag London
About this chapter
Cite this chapter
Pescariu, S., Sosdean, R. (2014). Complications of Cardiac Implantable Electronic Devices (CIED). In: Kibos, A., Knight, B., Essebag, V., Fishberger, S., Slevin, M., Țintoiu, I. (eds) Cardiac Arrhythmias. Springer, London. https://doi.org/10.1007/978-1-4471-5316-0_51
Download citation
DOI: https://doi.org/10.1007/978-1-4471-5316-0_51
Published:
Publisher Name: Springer, London
Print ISBN: 978-1-4471-5315-3
Online ISBN: 978-1-4471-5316-0
eBook Packages: MedicineMedicine (R0)